The Foreign Institutional Investors' (FIIs) turned net buyers for week as they bought equities worth Rs 342.74 crore.
While India's growth indicators remain strong, October's softer PMI and persistent trade uncertainties raise uncomfortable questions
Predictability of the IV may not be easily tradable for many but the negative relationship of IV with Futures can help in identifying expected Futures movement.
The Dow Jones Industrial Average rose 472.51 points, or 1.01%, to 47,207.12, the S&P 500 gained 53.25 points, or 0.79%, to 6,791.69 and the Nasdaq Composite gained 263.07 points, or 1.15%, to 23,204.87.
Bond yields inched lower as traders priced in a high likelihood of two interest rate reductions before the year is over.
In the short term, Eli Lilly and Novo Nordisk will continue to dominate due to strong branding and doctor trust. But in the medium to long term, expect Indian pharma to emerge as a major competitive force bringing innovation, affordability, and scale to one of the fastest-growing drug segments in history.
The year ahead is expected to deliver healthier stock returns — likely in line with the long-term average range of 12–15 percent, said Rakesh Vyas of Quest Investment Advisors.
The benchmark rose 1% at 12:20 p.m. in New York, helped by advances in eight of 11 sectors in the index, led by utilities and technology.
Promoter Docon Technologies has offloaded 53.3 lakh shares (10.06 percent of paid-up equity) in Thyrocare Technologies at Rs 1,252.03 per share for Rs 667.7 crore.
DIIs bought shares worth Rs 12,476 crore and sold shares worth Rs 12,303 crore. In contrast, FIIs purchased shares valued at Rs 11,768 crore while offloading shares worth Rs 11,147 crore.
The weekly options data suggests that the Nifty may trade in the 25,500–26,000 range in the short term, with a broader range between 25,000–26,500.
The IPO rush hour is building. The coming week will give you a glimpse of it. That’s not all, brace for a clutch of high frequency indicators like IIP and fiscal deficit. Earnings numbers are also rolling. Do keep a watch
Aditya Birla Sun Life AMC's assets under management stood at Rs 4.25 lakh crore at the end of September 2025, a growth of 11 percent.
Lenskart proposes to utilise the proceeds from the IPO for various strategic initiatives, including capital expenditure for setting up new Company-operated Company-owned (CoCo) stores in India
Dr Reddy's Laboratories Q2 FY26 results: Dr Reddy's declares fiscal second quarter results; check net profit, revenue, margin, other details.
The capacity is part of a 92.4 MW wind project located at Bhuj in the state.
Positive global cues weighed on the market sentiment, which led to partial recovery on October 24
ITC Hotels Q2 Results: The company's hotels business generated a revenue of Rs 822.80 crore in Q2 FY26, marking a rise of nearly 8% on-year from the Rs 763.48 crore generated in same period last year.
The three heavyweights -- Axis Bank, HDFC Bank and SBI -- had risen between 2.9 percent and 7.6 percent over the past five sessions, supported by strong second-quarter results across the banking sector.
Cipla, HUL, Adani Ports, Max Healthcare, UltraTech Cement were among top losers on the Nifty, while gainers were Hindalco, Bharti Airtel, ONGC, Shriram Finance, ICICI Bank.
Catch Nandita Khemka and Yatin Mota in conversation with Nirav Chheda, Nirmal Bang and Sandeep Bagla, TRUST Mutual Fund
Benchmark indices ended lower as profit-taking in banking and consumer stocks halted a six-session winning streak, with traders turning cautious amid uncertainties.
SBI Life Insurance Q2 results: SBI Life declares fiscal second quarter financial results. Check net profit, premium income, key ratios, other details
Shanthi Gears Q2 Results: The firm's revenue from operations meanwhile fell nearly 15% YoY to Rs 132 crore in Q2 FY26, from Rs 155 crore in Q2 FY25.
Brokerages expect the insurer to benefit from a better product mix in the second quarter.